Improvement of type 2 diabetes mellitus after gastric cancer surgery: Short-term outcome analysis after gastrectomy

Table 3 Degree of diabetes mellitus control after surgery n (%)

	STG BI (n = 36)			STG BII (n = 16)			TG (n = 12)
	3 mo	6 mo	12 mo	3 mo	6 mo	12 mo	3 mo	6 mo	12 mo
Stationary	16 (44.4)	16 (44.4)	15 (41.7)	8 (50)	8 (50)	6 (37.5)	6 (50)	7 (58.3)	6 (50)
Improved	19 (52.8)	20 (62.5)	21 (58.3)	8 (50)	8 (50)	9 (56.2)	6 (50)	4 (33.3)	5 (41.7)
Remission	1 (2.8)	0	0	0	0	1 (6.2)	0	1 (8.3)	1 (8.3)
Medication stopped	6 (16.7)	6 (16.7)	6 (16.7)	2 (12.5)	2 (12.5)	4 (25)	3 (25)	3 (25)	3 (25)

Stationary: No change in medication, or patients except improved and remission criteria; Improved: Reduced medication and a reduction in fasting blood glucose (FBS) or HbA1c; Remission: No medication and FBS < 126 mg/dL and HbA1c < 6.0%. STG BI: Subtotal gastrectomy with Billroth I anastomosis; STG BII: Subtotal gastrectomy with Billroth II anastomosis; TG: Total gastrectomy.